Nanospanlastic Vesicles as Novel Strategies for Enhancing Anti-Glaucoma Drug Bioavailability
January 2025
in “
The Pharma Innovation
”
Studysummary This review discusses how nanospanlastics, a type of ultra deformable vesicular nanocarrier, could enhance glaucoma management by improving the delivery and effectiveness of intraocular pressure-lowering agents, tackling adherence challenges, and advancing targeted therapies, according to the authors.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on thepharmajournal.com →